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biliary stent as a method for repair o1 arterial injury [pseodoaneurysms, 
artedal n~ture, artedovenous (AV) fistulae]. Four of five artedal lesions (2 
pseudoaneurysms, 1 AV fstula, t of 2 ruptured coronary arteries) were 
repaired percotaneeualy, utilizing a Palmaz" stent covered with the patient's 
harvested intact cephalic vein. The stent was inserted into the intact cephalic 
vein, balloon expanded to 3 ram, and one end of the vein was fixed to the 
stent with fine suture. The vein was pulled taut, and secured with suture at 
the opposite end. The covered stent was placed and secured onto a balloon 
catheter, and delivered to the artedal injury site (popliteal, axillary, or coronary 
artedas). Four procedures were Successful and without incident; the lone 
failure was due to the inability of the covered slant to negotiate the acute 
angle of enW into the cirumflex coronary artery, which was subsequently 
occluded by coil embolization. Followup angicgrams (at 6-12 months), and/or 
ultrasound data have demonstrated that all vessels were patent and repaired. 
Conclusion: These data indicate that autntogous vein may be an effec- 
tive, safe, simple, expandable, impermeable stent coveting which allows 
correction of a mydad of arterial injudes. 
5:15 • Urinary and Markers o!  Endothelial Circulating 
Dysfunct ion in Essential Hypertensives With 
Atherosclerct lc  Vascular Disease 
Raffeele De Catedna, Guido Lazzedni, Roberto Petrucci ~, 
Franco Carmasal 2 Giosue Catapeno 2 Giulia Dell'Omo 2, 
Roberto Peddnelli 2. Institute of Clinical Physiology, Pisa, Italy; 2 Clinica 
Medics, Pisa, Italy; ~ Radiologia, Pisa, italy 
Endothelial dysfunction precedes and accompanies the development of 
atheresclerosis. In search for markers of endothelial dysfunction and athemscle- 
resis in hypertensive patients, the plasma concentrations of the soluble(s) 
adhesion molecules ICAM-1 and VCAM-1 (ng/ml, EIA), and udnary albumin 
excretion (UAE,/~g/min, nephalometry; an average of three 12-hr ovemight 
collections) were assessed in 11 male essential mild-moderate ssential hy- 
pertensives (age: 59 =1: 8, BP: 156 :E 14/93 ± 11) without diabetes, obesity 
and renal insufficiency (s-creat < 1.2 mg/dl) and with clinical, angtographi- 
rally cont'irmed evidence of ilec-femoral athemsclerotic Fontaine's stage II 
peripheral vascular disease (Ell + Ath). EH-Ath were compared with 11 sex- 
matched uncomplicated essential hypertensives (E/-~, of comparable age (56 
:1: 9) and BP (151:1:10/97 :t: 9) without atherosclemtic disease, and 11 
normotensive controls (Contr, age: 57 ± 9, BP: 134 4- 9•80 :l: 10). The maxi- 
mum intima-media thickness (IMT max) value at the far wall of either c~mtid 
bifurcation (mm, high-resolution B-ModE ,z!trasonography) was taken as an 
independent index of systemic atherosclerotic involvement. Results (means 
+ SD or medians with range for asymmetdcaly distributed data) were 
IMT max UAE s-VCAM-1 s.ICAM.1 
EH + Ath 2.6 ± o.e* 27.3 (8-144) 998 (27,'~-1808) * 428 (301-546) 
EH 1.2 :t: 0.4 10.4 (6.5-18) 340 (236-975) 296 (205-630) 
Contr 1.1 ± 0.4 13.3 (6.1-20) 386 (204-821) 317 (202-405) 
• p < 0.01 vs EH and Contr 
In the group as a whole, UAE and s-VCAM-1 values were interrelated (r = 
0.49, p -~ 0.01, n = °,33). Both parameters (s-VCAM-1, r = 0,62, p < 0.0001 ;
UAE: r : 0.52, p < 0.001, n = 33) showed a statistically significant positive 
correlation with IMT max values. Thus, UAE and s-VCAM-1 were elevated 
in atheroscleretic hypertensives and correlated with the extent of carotid 
atherosalerosis. The data suggest that the abnormal values of the two in- 
dices are related to the underlying athemsclerotic disease and/or endothelial 
dysfunction. 
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4:00 
[ "~~ Long-Term Survival in Blacks Versus Whites With 
Coronary Artery Disease (CAD) 
Eric D. Peterson, Linda K. Shaw, Elizabeth R. DeLong, Charlotte L. Nelson, 
Lawrence H. Muhioaler, Daniel B. Mark. Duke University Medical Center, 
Durham, NC 
Little information is available regarding the prognosis of CAD in blacks. We 
examined racial differences in long.term survival among 12.402 Consecu- 
tive patients (10.3% black) who were found to have significant CAD (> 75% 
stsnosis in >_ 1 major coronary artery) at initial diagnostic cardiac catheteriza- 
tion (Cath) from 3/84 to 12/92. Compared with whites, blacks with significant 
CAD were more likely to be younger, female, hypertensive, diabetic, or have 
a pdor ML The duration from symptom onset to Cath was shorter in blacks 
than whites (median 2.8 vs. 4.0 months, p < 0.01 ). At Cath, blacks and whites 
had similar rates of 2-vessel (32 vs. 30'/0) and 3-vsssel disease (32 vs. 33%), 
both p • 0.05. Blacks, however, had slightly lower ejection fractions (median 
50 vs 52%. p < 0.01). 
Unadjusted 5-yr suwival was signiticantly lower in blacks with CAD com- 
pared with whites (74 vs. 81%, p < 0.01). After adjustment for age. anginal 
and CHF symptoms, acute MI, comorbidtty coronary anatomy, mitral valve 
disease, and left ventdeular function using a Cox survival model, blacks con: 
tinued to have a significantly worse long-term prognosis: adjusted black/white 
dsk ratio 0,80 (95% confidence interval 0.70-0,91). 
Conclusion: Despite similar initial disease sevedty, the icng-term prognosis 
in blacks with CAD was worse than whites. Known risk factors only partially 
account for these differences. Other factors (including non-medical ones) 
may play an important role in the outcomes of black CAD patients. 
4:15 
|771-2) Changes in Coronary Heart Disease Risk Factors 
Associated With Menopause 
Wendy S. Post, Martin G. [.arson, Peter W.F, Wilson. The Framingham 
Heart Study, Framingham, MA 
We studied changes in coronary heart disease risk factors associated with 
natural menopause. Women in the Fremingham Offspdng Study were eligible 
if they were premenopausel at the baseline exam, between 40 and 57 years 
old at the follow-up (F/U) exam 8 years later, not receiving estrogen replace- 
ment, and tree of surgical menopause. There were 610 women eligible: 428 
(70.2%) remained premenopaucal (PRE) at F/U, and 182 (29.8%) undeP~vent 
natural menopause (POST). The mean age at base,re was 37.3 years in the 
PRE group and 44.5 years in the POST group. Thero was an increase in body 
mass index and hypertension, and a decrease i~l cigarette smoking dudng 
F/U, which did not differ significantly between tt~e h~,~ grG:-'p;, c.P,o~ adjusting 
for age and other selected vadabios. Mean changes in lipide dudng FlU (and 
mean baseline values) are presented below (in mg/dl), after adjusting for age, 
body mass index, cigarette smoking, and other selected variables. 
Total CHOL LOL CHOL HDL CHOL LDL/HDL Trig 
PRE +10.4 (190.8) +8.8 (118.8) -3.2 (57.2) +030 (2.27) +17.1 {~e.6) 
POST +24.9(192.2) +22.9(117.4) -0.9~57.t~I +0.42(2.20) +19.7(70.0) 
p < 0.0001 p < 0.0004. p = 0,06 p = 0.17 D : 0.63 
*p = significance of difference between groups. 
There was a greatar increase in total cholesterol (CHOL) and LDL CHOL 
in the POST wr~men. Although there was a small decrease in HDL CHOL 
in both groups dudng F/U, it was not associated with menopause, per se. 
Changes in LDL/HDL and triglycedde were not significantly associated with 
menopause. In conclusion, the elevated risk associated with menopause 
is partially explained by an increase in LDL cholesterol, but is not due 
to changes in tfiglyceride, body mass index, or hypertension. In addition, 
contrary to previous reports, there is no decrease in HDL CHOL associated 
wilh menopause. 
4:30 
~ Factor Vile Activity Arteriographically Defined and 
Coronary Artery Disease: Significant Associations 
in Afr ican Amer icans  and Women 
Henry RC. Well, Russell P. Tracy, Edward F. Philbin, Paul Jenkins, Chades 
K. Francis, Thomas A, Pearson. M.L Bassett Research Instit., 
Cooperstown, NY; Harlem Hospital Center, New York, NY 
Hemostatic factors (tibdnogen, Factor Vlic activity, and plasminogen acti- 
vator inhibitor-1 (PAl-l) have been associated with coronary artery disease 
(CAD) in white males, but little is known about their association with objec- 
tively defined CAD in African Amedcans (AA) and women. To study this, we 
measured CAD risk factors, including hemostatic factors and serum tipids 
and lipoproteins, in 317 male (M) and female (F) patients undergoing coro- 
nary artedography for suspected CAD, compadng levels between those with 
(cases) and without (controls) at least one coronary stenosis > 50%. There 
were no associations between CAD and fibdnngen or PAl-1 levels. However, 
Factor Vllc levels (as a % of normal) were consistently different between 
cases and controls: 
AAM AAF White M White F 
N 84 61 114 58 
Case 93.4 120.6 93.5 113.3 
Control 77.0 98.7 86.3 90.7 
P 0.025 0.029 0.27 0.018 
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Serum trlglycedde (TG) levels, a possible confounder, did not correlate 
equally with Factor VIIc activity across raca-sex groups and Factor Vllc 
remained associated with CAD after adjustment for TG. Factor VIIc activity 
may be associated with CAD, especially in African Americans and women. 
These consistent associations cannot be explained by coaasociations with 
TG, and require further study. 
4:45 
~'~' -~ Women Alter Myocardial Infarction Fare Worse Than 
Men, A 12-Year Follow-Up of 1120 Women end 3688 
Men Surviving Acute MI 
Michal Benderly, Solomon Behar, Hendefta Reicher-Reiss, Vaiontina Boyko, 
Ud Gold'oourt for the SPRINT Study Group. Neufeld Cardiac Research 
Institute, Sheba Medical Center, TeI-Hashomec Israel 
Although women have higher mortality rates than men dudng hospitaliza- 
tion for MI, confficting results have been reported regard'rag their long term 
prognosis. •We previously reported an increased mortality dsk for women 
dudng hospitalization (adjusted relative odds for women versus men: 1.72). 
An extended follow-up facilitated an analysis of 12-year mortality of 1120 
female and 3688 male MI survivors hospitalized in Israel dudng the years 
1981--83. Women discharged were older than men (66:1:9 and 60 :!: 11 
years respectively) and were more likely to exhibit co-morb~.d conditions (age 
adjusted prevalences of hypertension and diabetes were 1.4 and 1.5 times 
higher than in men). Dudng follow-up, 65% of women died compared to 520 
of men. Unadjusted (a) and adjusted (b) 12 years survival rates for women 
(dashed line) and men (solid line) are presented in the figure: 
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After Controlling for age, pre-infamtion characteristics and hospital course 
in a proportional hazard regression analysis, the risk of mortality in women 
was 20% higher then in men. Life table analysis indicated that the disadvan- 
tage of women evident in the first year following the index MI, is slit: apparent 
in the twelfth year of follow-up. 
5:15 
~ Validation and Stability of Cox Models to Predict 
Survival After Coronary Angioplasty 
William S. Weintreub, Andrzej S. KosinskL Emory University School of 
Medicine, Atlanta, Georgia 
To assess the validity of Cox model analysis to predict survival after coronary 
angioplasty, 10,785 patients were dwidnd into 7,190 training and 3,595 vail* 
dation patients. For training patients multivariate correlates of survival were 
older age, diabetes, reduced ejection fraction, congestive failure, angina 
class, hypertension (all p < 0.0001) and vessels diseased (p = 0.022). Each 
group was divided by age group in decades, < 40, 40-49, 50-59. 60--69, 
70-79, • 80, The pfeo'icted mortality in the training was compared to ob- 
served in valk/ation. The model was limited at extreme of age, < 40 and 
>_ 80 (left figure), with predicted st, v~al at times outside 95% confidence 
intervals. In the middle ranges of age, the predicted survival was largely 
within the narrower 95% confidence infenrals (right figure). 
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There was little difference in correlates between the total of 10,785 and 
the training roup of 7.190. As the population was further educed, drop out 
of covadates occurred: hypertension at 3,595, congestive failure at 2.175, 
angina class at 1,078, ejection fraction at 539 with angina class reemerging, 
and angina class and vessels diseased at 269. Distortions in hazard ratios 
increased with each step. Cox model analysis has limitations at the extremes 
of the population, and is subject o overmndeling with spurious results in 
small populations. 
5:00 
~ W h y  Do Smokers Have a Better Prognosis ~rdh 
Acute Myocardial infarction? Insights From the 
PAMI-2 Trial 
Bruce Bredie, Tern/Bowers, William O'Neill, John Griffin, Bryan Donohue, 
Constantino Constantini, C. Balestrini, Grego Stone, Denise E. Jonas, 
Cindy Grines. The Moses H. Cone Memorial Hospital, Greensboro, N.C.; 
Beaumont Hospital, Royal Oak, MI 
Thmmbotytio trials for acute myocardial infarction (AMI) have shown smokers 
have a more favorable prognosis vs. non-smokers. Adiustment for clinical 
variables has not completely explained this paradox. The PAMI-2 trial ob- 
tained acute angiographio data on AMI pts. prior to repoduaion with PTCA 
that might provide unique insight into this paradox. Current smokers had a 
lower mortality (0.8 vs. 2P, o, P = 0.04), less re-infarction (3.6 vs. 5.7%, P = 
0.20), and less recorrent ischemia (93 vs. 14%, P = 0.03). PTCA was equally 
effective in establishing TIMI 3 flow in smokers and non-smokers. There were 
strikin§ differences in baseline clinical and anglographic vafiablos between 
smokers and non-smokers. 
Current Smoker (N = 387) Non-Smoker (N= 496) P Value 
Age (yrs.) 54 4. 11 64 4.11 0.001 
Hypertension 41% 50% 0.007 
Diabetes 12% 18% 0.01 
Prior MI 10% 19% 0.001 
Prior CABG 1.3% 6.5% 0.001 
Lyric Eligible 76% 69% 0.03 
Muitiveseel CAD 31% 44% 0.001 
LVEF (%) 50.5 4- 12 48.6 4.12 0.02 
Smoking did not effect outcomes in a multivadable model that corrected 
for these clinical and angiographlc differences. 
Conclusion: Smokers present with AMI at a younger age, with fewer asceci- 
ated diseases, and less advanced coronary disease and better left ventricular 
function. Adjustment for differences in age and severity of disease completely 
explain the more benign prognosis of smokers. 
